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Abstract
Objective—This study examined associations between maternal lipid levels at mid-pregnancy 
and preterm delivery, medically indicated or spontaneous.
Design—Prospective cohort study.
Setting—Women were recruited from 52 clinics in five Michigan, U.S.A communities (1998–
2004).
Population—Pregnant women were enrolled at 15–27 weeks’ gestation and followed to delivery 
(n=3019).
Methods—A single blood sample was obtained at study enrollment. Blood lipids, i.e., total (TC), 
high-density lipoprotein (HDLc), low-density lipoprotein (LDLc) cholesterol, and triglycerides 
(TG), were measured on a subcohort (n=1,309).
Main Outcome Measures—There were 221 spontaneous, 100 medically indicated preterm 
deliveries and 988 term deliveries. Polytomous logistic regression models examined relations 
among cholesterol levels (Low: <10th %tile, Referent: 10th–<70th %tile, High: ≥70th %tile), 
quartiles of TG (Referent: first quartile) and delivery outcome (Referent: term).
Results—Odds of medically indicated preterm delivery were increased among women with low 
TC (adjusted odds ratio (aOR)= 2.04, 95% confidence interval (CI): 1.12,3.72), low HDLc 
(aOR=1.89, 95%CI: 1.04,3.42), or low LDLc (aOR=1.96, 95%CI: 1.09,3.54). Odds of 
spontaneous preterm delivery were increased among women with high TC (aOR=1.51, 95%CI: 
1.06,2.15), high LDLc (aOR=1.42, 95%CI: 0.99,2.04) or high TG (aOR=1.90, 95%CI: 1.21,2.97 
and aOR=1.72, 95%CI: 1.06,2.78 for third and fourth quartiles, respectively).
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Conclusions—Extremely low TC, HDLc and LDLc were associated with a modest increase in 
risk of medically indicated preterm delivery, while high TC, LDLc and TG modestly increased 
risk of spontaneous preterm delivery. Further research is needed to uncover explanations for these 
associations and to identify optimal ranges for maternal lipids.
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Introduction
The rate of preterm delivery has steadily increased in the USA for the past two decades, but 
has remained at ~12–13% since 2005 (1). Preterm delivery (PTD) accounts for ~69% of 
perinatal mortality (2), and a substantial proportion of long-term morbidity (3, 4). 
Socioeconomic and racial disparities continue to exist, with African-Americans having the 
highest rates of PTD (18%) (1). About 30–35% of PTD are medically indicated, with the 
remaining precipitated by spontaneous preterm labor or premature rupture of membranes 
(5).
Reasons for PTD remain unclear, although maternal vascular disturbances and infection/
inflammation have been implicated (5). Recently, studies have begun to examine maternal 
lipid profiles during pregnancy in relation to PTD. Maternal levels of total cholesterol (TC), 
high-density lipoprotein (HDLc), and low-density lipoprotein (LDLc) cholesterol, as well as 
triglycerides (TG), all increase in the 2nd and 3rd trimesters as a normal physiological 
response to pregnancy (6). Increased lipid levels contribute towards hormonal and 
nutritional support of a healthy pregnancy (7); however, extremely high levels may induce 
oxidative stress and have been linked to poorer birth outcomes in animal models (8) and 
atherosclerosis in human offspring (9, 10).
To date, seven studies have reported on maternal lipids in association with PTD risk. It was 
first noted that women on a low-cholesterol diet during pregnancy were significantly less 
likely to deliver preterm (11). Since then, studies have found that risk of spontaneous PTD 
was increased in association with higher levels of TC or TG and high non-HDLc (12–14), 
but decreased in association with high levels of HDLc (upper quartile) (15). One study also 
demonstrated that both low (< 10th percentile) and high (≥90th percentile) levels of TC were 
linked to increased odds of PTD; however, this study did not separate medically indicated 
and spontaneous PTD (16).
Previous work on the relation between maternal lipids and risk of PTD is limited by an 
almost exclusive focus on spontaneous PTD, as well as the use of differing cut-points for 
lipid levels, with most comparing “high” lipids to “lower” lipids despite suggestion of a U-
shape effect (16). The purposes of this study were to examine the shape of the relation 
between mid-pregnancy levels of maternal TC, HDLc, LDLc, and TG and risk of PTD, and 
then to determine whether low or high levels of these lipids were associated with odds of 
spontaneous and/or medically indicated PTD.
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Data from the Pregnancy Outcomes and Community Health (POUCH) Study were used to 
evaluate the aims. Pregnant women were enrolled during the 15th–27th week of pregnancy at 
52 clinics in five Michigan (USA) communities from 1998–2004 (17). Eligibility criteria 
included singleton pregnancy with no known chromosomal abnormality or birth defect, 
maternal serum alpha-fetoprotein (MSAFP) screen at 15–22 weeks, maternal age ≥ 15 years, 
no pre-existing diabetes mellitus, and proficiency in English. All women with high MSAFP 
levels (i.e. ≥ 2 multiples of the mean) were invited to participate because this biomarker has 
been previously associated with PTD (18). Women with normal MSAFP levels were 
stratified by race/ethnicity and randomly sampled into the cohort. Institutional review boards 
at Michigan State University, the Michigan Department of Community Health, and nine 
community hospitals approved the study.
The POUCH study enrolled 3038 women, and accomplished delivery follow-up for 3019 
women. A sub-cohort of women (n=1371) was selected to maximize resources for more 
detailed study (such as biomarker assays, placental pathology) and to permit sub-analyses of 
strata of particular interest. The sub-cohort included all women who delivered preterm (<37 
weeks), women who delivered at term but had high MSAFP levels, and a race-stratified 
sample of women with term deliveries and normal MSAFP levels, with oversampling of the 
African-American stratum. All analyses were weighted according to the probabilities of 
selection into the cohort and sub-cohort to remove bias due to oversampling from certain 
strata. Stored blood samples from 62 women in the sub-cohort lacked enough blood for lipid 
analyses, thus the final sample for this study included 1309 women (95% of the sub-cohort).
At enrollment, women signed consent forms, completed self-administered surveys and in-
person interviews with a study nurse, and had a non-fasting venous blood draw. Prenatal and 
labor and delivery records were abstracted and delivered placentas were collected and stored 
for pathology examination.
Blood samples were drawn at a mean gestational age of 22.4 weeks (range 15–27 weeks), 
centrifuged within 45 minutes of collection, aliquoted (1 ml), and stored at −80◦C until 
analyses. Samples were shipped on dry ice to the Nutrition Laboratory in the Department of 
Epidemiology at the University of Pittsburgh for lipid analyses. This laboratory has been 
included in the CDC-NHLBI Lipid Standardization Program since 1982, is CLIA certified 
and participates in CAP proficiency programs. TC (mg/dL) was determined using the 
enzymatic method of Allain et al. (19). HDLc (mg/dL) was measured directly using a 
homogeneous two-reagent method with materials obtained from Equal Diagnostics. LDLc 
(mg/dL) was calculated indirectly using the Friedewald equation: LDLc = TC– HDLc - 
0.2*(TG), except when total TG exceeded 400 mg/dL, in which case LDLc was measured 
directly using an automated spectrophotmetric assay (LDL Direct Liquid Select) from Equal 
Diagnostics (20). TG (mg/dL) were determined enzymatically using the Bucolo et. al. 
procedure (21). Duplicate samples with standards, control sera and serum calibrators were 
included in each run. The coefficients of variation ranged from 1.3 to 2.0%.
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Gestational age was calculated using the last menstrual period (LMP) unless it disagreed by 
more than two weeks with ultrasound conducted prior to 25 weeks gestation, in which case 
the ultrasound value was used. Accordingly, the LMP estimate was used in 76% of the entire 
cohort where the two estimates agreed and in 6% of the cohort where only LMP estimates 
were available. Ultrasound estimates were used for the remaining 18% of the cohort with 
absent or conflicting LMP estimates. PTD was defined as births before 37 weeks gestation. 
A physician and a labor and delivery nurse independently reviewed and abstracted data from 
prenatal and labor and delivery records to identify clinical circumstances leading to PTD. 
Spontaneous preterm labor was defined as intact membranes, regular contractions and 
cervical changes (≥2 cm dilation) in the absence of labor induction. Preterm premature 
rupture of membranes (PROM) was defined as rupture of membranes before or 
simultaneously with the initiation of spontaneous contractions. Women with either 
spontaneous labor or PROM leading to preterm delivery were combined into a single 
spontaneous PTD (sPTD) group for analyses. Medically indicated preterm delivery (Mi 
PTD) included women induced or given cesarean sections before onset of labor or PROM. 
Primary reasons for Mi PTD included gestational hypertensive disorders (n=39), intrauterine 
growth restriction (n=11), oligohydramnios (n=8), abruption (n=3), other maternal 
conditions including previous complications and placenta previa (n=23), and other fetal 
conditions including signs of fetal distress (n=16).
The enrollment interview and questionnaire provided information on demographics, medical 
and reproductive history, pre-pregnancy weight and height (body mass index (BMI) 
calculated as kg/m2), and smoking and alcohol intake during pregnancy. Maternal weight at 
the time of the blood draw was recorded. Medical record abstraction provided information 
on birthweight, preeclampsia/gestational hypertension, gestational diabetes, and placental 
abruption as previously described (22). Births were classified as small (<10th percentile), 
appropriate, or large (≥90th percentile) for gestational age using sex and gestational age-
specific birthweight cut-points (23). A single pathologist blinded to clinical information 
performed gross and microscopic evaluation of placentas. As previously described, these 
data were used to classify women as having histological chorioamnioitis and high vs. not 
high evidence of five placental vascular pathology constructs (24, 25). Placental evaluations 
were available for 1057 of the 1309 women with lipid levels.
Statistical analyses
Analyses were conducted with SAS (www.sas.com/statistics) version 9.2. Statistical 
significance was set at a two-sided alpha level of p<0.05. Sampling weights were used to 
remove bias due to oversampling of high MSAFP into the cohort and oversampling of high 
MSAFP, PTD, and African-Americans into the sub-cohort. Thus, weighted results account 
for the POUCH sampling scheme and should reflect the experience of the population of 
pregnant women that was initially sampled. Chi-squared testing was used to compare 
maternal characteristics by delivery status (term, sPTD Mi PTD). Lipid values were skewed, 
thus log-transformed values were used. Analysis of variance compared least square mean 
values of log transformed lipids by delivery status.
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Generalized additive models (PROC GAM) with cubic spline smoothing (degrees of 
freedom=3) were used to investigate the shapes of relations between maternal lipids and 
PTD, adjusted for maternal race, parity, and gestational age at time of the blood draw (26). 
Plots of relations were inspected to determine decile cut-points for lipid levels. Accordingly, 
women were categorized as having low (<10th), referent (10–<70th), and high (≥70th 
percentile) TC, HDLc, and LDLc values based on the distributions of these variables among 
women with normal MSAFP values who gave birth at term. Quartiles of TG were calculated 
based on women with normal MSAFP values who gave birth at term, and the lowest quartile 
was designated as referent.
The odds of sPTD and Mi PTD by lipid categorizations were estimated using logistic and 
polytomous logistic regression models. Since lipid values increase with gestational age and 
African-Americans are known to have more favorable lipid profiles than Whites, gestational 
age at the time of blood draw (continuous) and race (White/Others vs. African-American) 
were considered as covariates in all models (27, 28). Based on previous literature the 
following covariates were also considered: parity, pre-pregnancy BMI, maternal weight at 
blood draw, Medicaid status, marital status, education level, age, and smoking and/or 
alcohol use during pregnancy. Any variable that altered estimates of associations between 
lipid levels and PTD by more than 10% was retained in the adjusted models. Secondary 
analyses removed groups of women with higher risk of PTD based on pre-pregnancy BMI 
(<18.5 kg/m2, underweight women), diagnoses of preeclampsia/gestational hypertension, 
presence of histological chorioamnioitis, presence of placental vascular pathology, and birth 
size (small-for-gestational age) to assess whether their removal changed parameter estimates 
for relations between lipids and odds of PTD.
Results
Spontaneous PTD accounted for 7.4% and Mi PTD 3.3% of all deliveries. Women who 
delivered preterm were more likely to be African-American and enrolled in Medicaid 
compared to women who delivered at term (Table 1). The prevalence of preeclampsia/
gestational hypertension and small for gestational age births was also greater among Mi 
PTD vs. term deliveries.
Least square mean lipid values were adjusted for race, parity, and gestational week of blood 
draw and back-transformed from the log scale (Table 2). Lipid values for term deliveries 
were similar to those previously reported for second trimester measurements (6). 
Spontaneous PTD deliveries had significantly higher TC and TG values compared to term 
deliveries (p<0.05). Pre-pregnancy BMI was inversely but weakly correlated with TC (r=
−0.1, p<0.001), HDLc (r=−0.2, p<0.001) and LDLc (r=−0.1, p=0.002), and directly 
correlated with TG (r=0.2, p<0.001).
Results from the general additive modeling showed that the probability of PTD was greater 
than zero when log-transformed TC values were less than 5.18 or greater than 5.52, 
corresponding to the 10th and 70th percentiles of the distribution of TC among women with 
normal MSAFP values who gave birth at term (Figure 1). The shapes of the relations 
between HDLc or LDLc and PTD were similar and also suggested cut-points at the 10th and 
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70th percentiles (data not shown). In contrast, the general additive model for the relations 
between TG and PTD did not support a curvilinear term, but rather indicated a linear 
relation (Figure 2).
Odds of Mi PTD were increased among women with low TC, HDLc, or LDLc, while odds 
of sPTD were increased among women with high TC or LDLc (Table 3), as compared to 
women with referent cholesterol values. Associations were adjusted for maternal race, 
gestational week of blood draw, and parity. No other covariate, including maternal weight or 
pre-pregnancy BMI, met criteria for inclusion in the cholesterol models. TG levels in the 
upper two quartiles (first quartile as referent) were also associated with increased odds of 
sPTD. TG models additionally adjusted for maternal weight at blood draw.
Results were not appreciably altered by removing women who were underweight pre-
pregnancy (n=61), diagnosed with preeclampsia/gestational hypertension (n=92), displayed 
histological chorioamnioitis (n=128), had high ratings of placental vascular pathologies 
(n=120–435 depending on the construct), or gave birth to small-for-gestational age infants 
(n=141). Removal of women with PROM (n= 88) attenuated associations between sPTD 
and high TC (aOR=1.40, 95% CI: 0.91–2.16) and higher quartiles of TG (aOR=1.61, 95% 
CI: 0.91–2.83 and aOR=1.70, 95% CI: 0.94–3.07 for the third and fourth quartiles, 
respectively) to statistical non-significance, but the direction of effects remained the same. 
Removal of women whose blood draw occurred prior to 20 weeks of gestation also did not 
affect the reported associations.
Discussion
Our analyses revealed that PTD had a U-shaped relation with TC, HDLc, and LDLc, but a 
linear relation with TG. When PTD was categorized by clinical circumstances we observed 
that high TC and LDLc values were associated with increased odds of sPTD while 
extremely low TC, HDLc, and LDLc values were associated with increased odds of Mi 
PTD. Higher TG (third or fourth quartiles) were also linked to increased odds of sPTD/
PROM compared to low values. Removal of subgroups of women at higher risk for PTD did 
not appreciably alter findings.
A body of literature on lipids and PTD is accumulating; however, differences in gestational 
age at sampling, choice of referent group, and lipid cut-points challenge comparisons across 
studies. In the only previous study that reported a U-shape relation between TC and PTD, 
Edison et al. found that TC values in the lowest or highest 10th percentiles were associated 
with a 2–3 fold increase in odds of PTD (16). The range of TC values in the Edison study 
(93–435 mg/dl) were similar to those seen here (119–464 mg/dl). While “low” and “high” 
TC cutpoints differed slightly, our results are markedly similar and extend their findings by 
separately considering sPTD and MI PTD. Another investigation among 651 Greek women 
examined maternal lipids in relation to sPTD and Mi PTD separately (29). The Greek study 
found no associations between sPTD and linear increases in maternal TC, HDLc, LDLc, or 
TG, but a significantly increased risk of Mi PTD with increasing TC levels (29). These 
authors did not report on effects of low lipid values, nor did they provide information on the 
range of lipid values for their sample (29).
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Others have focused on maternal lipids in relation to sPTD only (12–15). A study of 651 
Canadian women examined odds of sPTD in relation to maternal lipids with the lowest 
quartile designated as referent (15). They found that increasing quartiles of TC and LDLc 
were unrelated to sPTD, but that being in the highest quartile of HDLc significantly 
decreased odds of sPTD (15). Once again, it is difficult to compare these results to ours as 
the lowest lipid values were used as the referent group. A series of studies by Catov et al. 
consistently showed that “dyslipidemia” was associated with more than twice the odds of 
sPTD (12–14). In these studies, dyslipidemia was defined as having elevated (>1 standard 
deviation above the mean) TC or TG (13, 14), or as having elevated (≥90th percentile vs. 
10–<90th percentile) non-HDL cholesterol (12). Catov et al. also showed that the 
dyslipidemia-sPTD association persisted in the presence or absence of inflammation (i.e. 
high C-reactive protein) (14), or of markers of the fibrinolytic cascade (i.e. elevated 
thrombin-antithombin III complex) (12). These findings parallel ours showing minimal 
impact of removing women with clinical complications or a particular set of placental 
pathologies. Taken together, the results of these studies with ours point towards the 
robustness of the association between elevated maternal lipids and sPTD in samples drawn 
from USA populations.
The mechanisms linking low or high maternal lipid levels and PTD risk remain poorly 
understood. Physiological increases in maternal TC, HDLc and LDLc are important for fetal 
development of cell membranes, steroid synthesis, cell proliferation and differentiation, and 
metabolic regulation, and increases in maternal TG provide a reservoir of fatty acids for fetal 
growth (7). We found that low lipids increased odds of Mi PTD, which is somewhat 
surprising given that high lipids (TC and TG) are associated with preeclampsia (30, 31). 
However, low third trimester maternal TC and LDLc levels have been associated with 
delivering intrauterine growth restricted infants (32, 33). We removed small-for-gestational 
age deliveries because that group had particularly low lipid levels; however, the associations 
among low TC and LDLc and Mi PTD remained. It is possible that abnormal fetal 
development resulting in suboptimal growth (birthweight in the lower range of being 
appropriate-for-gestational age) and Mi PTD may also reduce the stimulus for cholesterol 
synthesis during pregnancy leading to our observed associations. Evidence among non-
pregnant adults suggest that serum lipid levels are significantly lower during acute illness 
(34), thus low cholesterol levels may also mark presence of a medical condition that is the 
underlying cause of Mi PTD. On the opposite end, we saw that high lipids increased odds of 
sPTD. High lipids have been associated with oxidative stress and systemic inflammation, 
and may also be related to placental dysfunction or microvascular injuries that lead to sPTD 
(12, 35). Importantly, results remained after removing women with established risk factors 
for PTD (such as underweight pre-pregnancy, preeclampsia/gestational hypertension, 
histological chorioamnioitis, placental vascular pathology, and small-for-gestational age 
deliveries), indicating that atypical maternal lipid levels may mark alternative pathways to 
sPTD or Mi PTD that are not well described.
Several limitations should be noted. Similar to previous studies on pregnancy lipids and 
PTD (12, 14–16, 29), maternal lipids were sampled only once in pregnancy, thus we were 
unable to describe the trajectory of lipid levels or compare pre-pregnancy and pregnancy 
levels. It is important to note that our results were not affected by timing of the blood draw 
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as associations were unchanged by restricting analyses only to women whose lipids were 
measured in the 20–27th week of gestation (data not shown). Also similar to previous reports 
(12–15), our participants were not fasted, thus lipid levels may have been influenced by the 
woman’s last meal. However, studies comparing fasting versus non-fasting lipid levels show 
minimal differences (<5%) for TC, HDLc, and LDLc values, while TG are ~15% higher in 
the non-fasted state (36, 37). Extra variation induced by using non-fasted lipid levels should 
affect women with term and preterm deliveries similarly and thus have a non-differential 
effect, most likely attenuating results. It is surprising that TC and LDLc values were 
inversely, albeit weakly, correlated with pre-pregnancy BMI given that 
hypercholesterolemia is associated with overweight/obesity (38). It is possible that 
pregnancy-related increases in lipid levels disrupted expected correlations with pre-
pregnancy BMI. Our internal cut-points for low and high lipid levels may not generalize to 
other populations. Finally, the use of last menstrual period to measure gestational age at 
delivery may be considered a limitation. However, we used a standard protocol of only 
using last menstrual period dating if it agreed within two weeks of ultrasound dating, thus 
we are reasonably confident in our assessment of gestational age.
Despite these limitations our results add to the existing literature on maternal lipids and 
PTD. Nonparametric modeling allowed us to detect a U-shape relationship between TC, 
HDLc, and LDLc and risk of PTD, perhaps reconciling inconsistencies across studies that 
focused on only one end of the continuum. Unlike most previous literature on lipids and 
PTD (11–16), we also considered clinical subtypes, and were able to shed more light on a 
previously documented U-shape relation between TC and PTD (16). Modeling each lipid 
individually with PTD also provided greater specificity than past studies which combined 
women with high TC or high TG (13, 14). As clinicians move towards measuring more 
biomarkers during pregnancy to assess risk of PTD, lipids may turn out to be a useful 
component of a biomarker risk profile.
More research is needed to identify the biological mechanisms leading to increased risk of 
PTD and to determine healthy ranges for lipids during pregnancy that optimize birth 
outcomes. Ideally, both pre-pregnancy and pregnancy lipid profiles should be measured in 
order to determine if one or both are associated with risk of PTD. Future studies should also 
measure markers of inflammation and/or oxidative stress to determine whether high lipids 
are related to these sPTD pathways, as well as other indicies of placental/fetal health to 
better evaluate mechanisms linking low lipids to Mi PTD.
Conclusions
In conclusion, low lipid values (TC, HDLc, and LDLc) were uniquely associated with a 
modestly increased risk of medically indicated preterm delivery while high lipids (TC, 
LDLc, and TG) were associated with an increased risk of spontaneous preterm delivery. 
Given that one in six women in the United States are dyslipidemic, it is important to more 
fully understand the impact of maternal lipids on pregnancy outcomes (39).
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Table 1
Participant Characteristics by Delivery Status (n (Weighted Column Percent)), Pregnancy Outcomes and 










  White/Other 553 (76.4) 148 (66.3) 71 (68.9) <0.001
  African-American 435 (23.6) 73 (33.7) 29 (31.1)
Paritya
  Nulliparous 409 (41.0) 101 (46.5) 38 (37.9) 0.27
  Parous 579 (59.0) 119 (53.5) 62 (62.1)
Living Arrangementb
  Live alone 351 (26.5) 70 (32.6) 27 (27.0) 0.17
  Live with partner/spouse 636 (73.5) 149 (67.4) 73 (73.0)
Medicaid
  Yes 558 (48.2) 129 (58.4) 52 (51.9) 0.02
Age
  ≤19 years 151 (12.4) 35 (16.5) 12 (11.6)
  20–29 years 572 (57.6) 125 (56.9) 60 (59.8) 0.52
  ≥30 years 265 (30.0) 61 (26.6) 28 (28.6)
Education
  < High School 223 (18.4) 51 (23.6) 24 (25.3)
  High School 277 (26.9) 66 (30.0) 28 (27.5) 0.09
  > High School 488 (54.8) 104 (46.4) 48 (47.2)
Pre-pregnancy BMI
  ≤18.4 kg/m2 44 (3.6) 14 (6.8) 3 (2.7)
  18.5–24.9 kg/m2 439 (46.9) 107 (47.9) 40 (41.4) 0.17
  25–29.9 kg/m2 226 (23.3) 44 (20.5) 20 (20.6)
  ≥30 kg/m2 279 (26.1) 56 (24.8) 37 (35.4)
Smoking in pregnancy
  Yes 274 (27.2) 67 (30.9) 28 (26.2) 0.52
Gestational Diabetes
  Yes 46 (5.5) 12 (4.7) 7 (6.6) 0.81
Hypertension
None 901 (91.1) 205 (92.8) 59 (58.0)
  PE/Gestational Hypertension 56 (5.8) 4 (1.9) 32 (33.5) <0.001
  Chronic Hypertension 31 (3.0) 12 (5.3) 9 (8.5)
Size for Gestational Agec
  Small (<10th percentile) 121 (9.8) 2 (0.8) 18 (17.8)
  Appropriate 766 (77.6) 187 (84.3) 72 (73.6) <0.001
  Large (≥90th percentile) 100 (12.6) 32 (14.9) 9 (8.6)
Timing of Blood Draw






















  <20 weeks gestation 148 (15.1) 47 (20.4) 18 (18.6) 0.36
  20–27 weeks gestation 840 (84.8) 174 (79.6) 82 (81.4)
BMI=Body mass index; Mi PTD= Medically indicated preterm delivery; PE=Preeclampsia; sPTD=Spontaneous preterm delivery
*
P-values indicated significant differences among Term, sPTD, and MI PTD delivery groups
a
n=1 woman missing information on parity
b
n=3 women missing information on living arrangement
c
n=2 women missing information on size for gestational age
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